$JNJ · Johnson & Johnson

Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, filed a Form 4 reporting transactions in the company’s common stock on August 13, 2026. He exercised employee stock options to acquire 123,291 shares at an exercise price of $115.67 per share, increasing his direct holdings to 399,258 shares.

On the same day, Duato sold the same number of shares in two separate transactions. He sold 20,976 shares at $262.00 per share and 102,315 shares at $261.00 per share, disposing of all 123,291 shares acquired through the option exercise. Following these sales, his direct beneficial ownership in Johnson & Johnson common stock was 275,967 shares. The filing also lists indirect holdings of 1,018 shares through a 401(k) plan and 30,852 shares held by his spouse.

The exercised options were originally granted under the company’s Long-Term Incentive Plan and became exercisable on the third anniversary of the grant date. The option tranche was set to expire on February 13, 2027, and no options from that grant remain beneficially owned after the reported transaction.